3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Neuroblastoma
12
Recurrence
3
Osteosarcoma
3
Neoplasm Metastasis
3
Melanoma
3
Brain Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neurofibrosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia
2
Glioma
2
Glioblastoma
2
Desmoplastic Small Round Cell Tumor
2
Breast Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Paraganglioma
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive
1
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
fludarabine phosphate
×
CNS
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled